Form 4 for PEN Penumbra Inc
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-13 · accession 0001796057-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-18 | 2026-02-13+ | PEN | Yuen Maggie | CFO | A - Grant | $0.00 | +5,260 | 20.8K | +34% | $0 |
| 2026-02-18 | 2026-02-15 | PEN | Yuen Maggie | CFO | F - Tax | $339.30 | -481 | 18.2K | -3% | -$163.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-13 | A | A | 2,630 | $0.00 | 18,636 | D | — | — | (F1) On February 13, 2026, the Reporting Person was granted 2,630 restricted stock units (RSUs) under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on February 15, 2026, February 15, 2027, February 15, 2028 and February 15, 2029, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date. (F2) A portion of these shares is subject to vesting. |
| 2 | Common | Common Stock | 2026-02-15 | F | D | 481 | $339.30 | 18,155 | D | — | — | (F2) A portion of these shares is subject to vesting. |
| 3 | Common | Common Stock | 2026-02-17 | A | A | 2,630 | $0.00 | 20,785 | D | — | — | (F4) On February 17, 2026, the Reporting Person was granted 2,630 RSUs under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on an annual basis, beginning on February 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to continued service by the Reporting Person through such date. (F2) A portion of these shares is subject to vesting. |